Portola Says Stock Drop Was 'Reversal Of Fortune,' Not Fraud

By Reenat Sinay · July 2, 2020, 7:11 PM EDT

Portola Pharmaceuticals pushed a California federal judge to toss a proposed class action accusing the company of misstating the actual market value of its blood coagulant, Andexxa, arguing there is no...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

Hayden v. Portola Pharmaceuticals, Inc. et al

Case Number

3:20-cv-00367

Court

California Northern

Nature of Suit

Securities/Commodities

Date Filed

January 16, 2020